Overview
- Editors:
-
-
Ronald B. Herberman
-
National Cancer Institute, Frederick Cancer Research Facility, Frederick, USA
Access this book
Other ways to access
Table of contents (8 chapters)
-
-
-
- William E. Fogler, Isaiah J. Fidler
Pages 83-106
-
-
-
-
- Linda M. Karavodin, Sidney H. Golub
Pages 215-256
-
- Richard V. Smalley, Cedric W. Long, Stephen A. Sherwin, Robert K. Oldham
Pages 257-300
-
- Philip D. Greenberg, Martin A. Cheever, Alexander Fefer
Pages 301-335
-
Back Matter
Pages 337-348
About this book
Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general onco logy textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often prelimi nary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by divid ing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.
Editors and Affiliations
-
National Cancer Institute, Frederick Cancer Research Facility, Frederick, USA
Ronald B. Herberman
